Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
16484 | 651 | 40.3 | 92% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
456 | 3 | VIRGIN OLIVE OIL//OLIVE OIL//HYDROXYTYROSOL | 25234 |
1534 | 2 | OXIDIZED LDL//ATHEROSCLEROSIS//LOX 1 | 7455 |
16484 | 1 | LOX 1//LECTIN LIKE OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1//VASC PHYSIOL | 651 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LOX 1 | authKW | 5657002 | 25% | 74% | 164 |
2 | LECTIN LIKE OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1 | authKW | 1259031 | 6% | 73% | 37 |
3 | VASC PHYSIOL | address | 648555 | 7% | 31% | 44 |
4 | LECTIN LIKE OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1 LOX 1 | authKW | 328328 | 1% | 100% | 7 |
5 | LOX 1 RECEPTOR | authKW | 300183 | 1% | 80% | 8 |
6 | OLR1 | authKW | 271367 | 1% | 64% | 9 |
7 | SOLUBLE LECTIN LIKE OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1 | authKW | 241219 | 1% | 86% | 6 |
8 | LECTIN LIKE OXIDIZED LDL RECEPTOR 1 | authKW | 223475 | 1% | 53% | 9 |
9 | SOLUBLE LECTIN LIKE OXIDIZED LDL RECEPTOR 1 | authKW | 195432 | 1% | 83% | 5 |
10 | LECTIN LIKE OXIDIZED LOW DENSITY LIPOPROTEIN | authKW | 187616 | 1% | 100% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Peripheral Vascular Diseases | 3181 | 21% | 0% | 136 |
2 | Cardiac & Cardiovascular System | 2318 | 24% | 0% | 157 |
3 | Biochemistry & Molecular Biology | 415 | 24% | 0% | 158 |
4 | Biophysics | 338 | 9% | 0% | 60 |
5 | Hematology | 280 | 7% | 0% | 46 |
6 | Cell Biology | 266 | 12% | 0% | 79 |
7 | Pharmacology & Pharmacy | 187 | 12% | 0% | 80 |
8 | Medicine, Research & Experimental | 166 | 7% | 0% | 46 |
9 | Physiology | 84 | 5% | 0% | 32 |
10 | Multidisciplinary Sciences | 82 | 2% | 0% | 14 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | VASC PHYSIOL | 648555 | 7% | 31% | 44 |
2 | SANQUAN | 120604 | 1% | 43% | 6 |
3 | STEM CELL BIOTHE TECHNOL | 93808 | 0% | 100% | 2 |
4 | CENT ARKANSAS VET HEALTHCARE SYST | 73584 | 3% | 8% | 19 |
5 | AGCY EVALUAT | 46904 | 0% | 100% | 1 |
6 | AUTOIMMUN IMMUNOTHER Y | 46904 | 0% | 100% | 1 |
7 | BEREICH GEFASSENDOTHEL MIKRIZIRKULAT | 46904 | 0% | 100% | 1 |
8 | BIOMOL CRYSTALLOG GRP | 46904 | 0% | 100% | 1 |
9 | CARDIOVASC DISZHONGDA HOSP | 46904 | 0% | 100% | 1 |
10 | CARDIOVASC SOUTHEAST UNIV CARDIOL | 46904 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS | 5068 | 2% | 1% | 11 |
2 | VASCULAR PHARMACOLOGY | 4138 | 2% | 1% | 10 |
3 | CARDIOVASCULAR DRUGS AND THERAPY | 4073 | 2% | 1% | 13 |
4 | ATHEROSCLEROSIS | 2515 | 4% | 0% | 24 |
5 | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2241 | 3% | 0% | 19 |
6 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS | 1991 | 1% | 1% | 5 |
7 | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 1117 | 6% | 0% | 41 |
8 | CARDIOVASCULAR RESEARCH | 845 | 2% | 0% | 12 |
9 | CIRCULATION RESEARCH | 650 | 2% | 0% | 12 |
10 | CIRCULATION JOURNAL | 639 | 1% | 0% | 8 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | NAVARRA, T , DEL TURCO, S , BERTI, S , BASTA, G , (2010) THE LECTIN-LIKE OXIDIZED LOW-DENSITY LIPOPROTEIN RECEPTOR-1 AND ITS SOLUBLE FORM: CARDIOVASCULAR IMPLICATIONS.JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS. VOL. 17. ISSUE 4. P. 317 -331 | 90 | 86% | 41 |
2 | XU, SW , OGURA, S , CHEN, JW , LITTLE, PJ , MOSS, J , LIU, PQ , (2013) LOX-1 IN ATHEROSCLEROSIS: BIOLOGICAL FUNCTIONS AND PHARMACOLOGICAL MODIFIERS.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 70. ISSUE 16. P. 2859-2872 | 83 | 75% | 39 |
3 | YOSHIMOTO, R , FUJITA, Y , KAKINO, A , IWAMOTO, S , TAKAYA, T , SAWAMURA, T , (2011) THE DISCOVERY OF LOX-1, ITS LIGANDS AND CLINICAL SIGNIFICANCE.CARDIOVASCULAR DRUGS AND THERAPY. VOL. 25. ISSUE 5. P. 379-391 | 97 | 64% | 44 |
4 | MEHTA, JL , CHEN, JW , HERMONAT, PL , ROMEO, F , NOVELLI, G , (2006) LECTIN-LIKE, OXIDIZED LOW-DENSITY LIPOPROTEIN RECEPTOR-1 (LOX-1): A CRITICAL PLAYER IN THE DEVELOPMENT OF ATHEROSCLEROSIS AND RELATED DISORDERS.CARDIOVASCULAR RESEARCH. VOL. 69. ISSUE 1. P. 36-45 | 60 | 86% | 240 |
5 | REISS, AB , ANWAR, K , WIRKOWSKI, P , (2009) LECTIN-LIKE OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1 (LOX-1) IN ATHEROGENESIS: A BRIEF REVIEW.CURRENT MEDICINAL CHEMISTRY. VOL. 16. ISSUE 21. P. 2641-2652 | 90 | 71% | 13 |
6 | PIRILLO, A , NORATA, GD , CATAPANO, AL , (2013) LOX-1, OXLDL, AND ATHEROSCLEROSIS.MEDIATORS OF INFLAMMATION. VOL. . ISSUE . P. - | 60 | 67% | 55 |
7 | CHEN, XP , ZHANG, TT , DU, GH , (2007) LECTIN-LIKE OXIDIZED LOW-DENSITY LIPOPROTEIN RECEPTOR-1, A NEW PROMISING TARGET FOR THE THERAPY OF ATHEROSCLEROSIS ?.CARDIOVASCULAR DRUG REVIEWS. VOL. 25. ISSUE 2. P. 146-161 | 65 | 73% | 51 |
8 | DUNN, S , VOHRA, RS , MURPHY, JE , HOMER-VANNIASINKAM, S , WALKER, JH , PONNAMBALAM, S , (2008) THE LECTIN-LIKE OXIDIZED LOW-DENSITY-LIPOPROTEIN RECEPTOR: A PRO-INFLAMMATORY FACTOR IN VASCULAR DISEASE.BIOCHEMICAL JOURNAL. VOL. 409. ISSUE . P. 349-355 | 48 | 81% | 92 |
9 | SAWAMURA, T , WAKABAYASHI, I , OKAMURA, T , (2015) LOX-1 IN ATHEROSCLEROTIC DISEASE.CLINICA CHIMICA ACTA. VOL. 440. ISSUE . P. 157 -163 | 51 | 65% | 11 |
10 | CHEN, MJ , MASAKI, T , SAWAMURA, T , (2002) LOX-1, THE RECEPTOR FOR OXIDIZED LOW-DENSITY LIPOPROTEIN IDENTIFIED FROM ENDOTHELIAL CELLS: IMPLICATIONS IN ENDOTHELIAL DYSFUNCTION AND ATHEROSCLEROSIS.PHARMACOLOGY & THERAPEUTICS. VOL. 95. ISSUE 1. P. 89 -100 | 48 | 89% | 187 |
Classes with closest relation at Level 1 |